FY2025 Earnings Estimate for TARS Issued By Lifesci Capital
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities researchers at Lifesci Capital issued their FY2025 earnings estimates for Tarsus Pharmaceuticals in a report released on Wednesday, February 26th. Lifesci Capital analyst C. Jubinville expects that the company will earn ($1.65) per share for the year. The consensus estimate for Tarsus Pharmaceuticals’ current full-year earnings […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities researchers at Lifesci Capital issued their FY2025 earnings estimates for Tarsus Pharmaceuticals in a report released on Wednesday, February 26th. Lifesci Capital analyst C. Jubinville expects that the company will earn ($1.65) per share for the year. The consensus estimate for Tarsus Pharmaceuticals’ current full-year earnings […]
